► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />The European Medicines Agency has launched a new fast-track approval process for breakthrough drugs, mirroring similar schemes in the US. But can regulators strike the right balance between speed and safety?<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
